Latest Insider Transactions at Horizon Therapeutics Public LTD CO (HZNP)
This section provides a real-time view of insider transactions for Horizon Therapeutics Public LTD CO (HZNP). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Horizon Therapeutics Public Ltd Co to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Horizon Therapeutics Public Ltd Co's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 28
2021
|
Timothy P Walbert Chairman, President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
34,833
+3.8%
|
-
|
|
Jul 22
2021
|
Michael G Grey Director |
SELL
Open market or private sale
|
Direct |
5,000
-60.0%
|
$500,000
$100.03 P/Share
|
|
Jul 22
2021
|
Michael G Grey Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$10,000
$2.37 P/Share
|
|
Jul 08
2021
|
Timothy P Walbert Chairman, President and CEO |
SELL
Bona fide gift
|
Direct |
5,000
-0.59%
|
-
|
|
Jul 08
2021
|
Barry Moze EVP, Chief Admin. Officer |
SELL
Open market or private sale
|
Direct |
35,076
-12.36%
|
$3,226,992
$92.37 P/Share
|
|
Jul 01
2021
|
Elizabeth H.Z. Thompson EVP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
5,988
-21.6%
|
$574,848
$96.59 P/Share
|
|
Jul 01
2021
|
Elizabeth H.Z. Thompson EVP, Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
12,077
+30.35%
|
-
|
|
Jul 01
2021
|
Jeffrey W Sherman EVP and Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
54,789
-29.84%
|
$5,204,955
$95.0 P/Share
|
|
Jul 01
2021
|
Jeffrey W Sherman EVP and Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,287
-36.71%
|
$502,265
$95.0 P/Share
|
|
Jun 30
2021
|
Timothy P Walbert Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-1.43%
|
$2,350,000
$94.29 P/Share
|
|
Jun 11
2021
|
Jeffrey W Sherman EVP and Chief Medical Officer |
BUY
Bona fide gift
|
Direct |
5,287
+9.18%
|
-
|
|
Jun 11
2021
|
Jeffrey W Sherman EVP and Chief Medical Officer |
SELL
Bona fide gift
|
Indirect |
5,287
-10.56%
|
-
|
|
Jun 10
2021
|
Miles W Mc Hugh Sr VP & Princ. Acctg Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,477
-3.89%
|
$137,361
$93.95 P/Share
|
|
Jun 10
2021
|
Miles W Mc Hugh Sr VP & Princ. Acctg Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,334
+8.07%
|
-
|
|
Jun 01
2021
|
Timothy P Walbert Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-1.4%
|
$2,275,000
$91.61 P/Share
|
|
May 25
2021
|
Jeffrey W Sherman EVP and Chief Medical Officer |
BUY
Bona fide gift
|
Indirect |
12,304
+19.73%
|
-
|
|
May 25
2021
|
Jeffrey W Sherman EVP and Chief Medical Officer |
SELL
Bona fide gift
|
Direct |
12,304
-20.75%
|
-
|
|
May 14
2021
|
Paul W. Hoelscher EVP, CFO |
SELL
Open market or private sale
|
Indirect |
102,925
-37.41%
|
$9,263,250
$90.01 P/Share
|
|
May 11
2021
|
Jeff Kent Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,592
+13.09%
|
$277,024
$22.14 P/Share
|
|
May 10
2021
|
William F Daniel Director |
SELL
Open market or private sale
|
Direct |
20,000
-99.59%
|
$1,720,000
$86.79 P/Share
|
|
May 10
2021
|
William F Daniel Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+50.0%
|
$240,000
$12.7 P/Share
|
|
Apr 30
2021
|
Timothy P Walbert Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-1.36%
|
$2,350,000
$94.65 P/Share
|
|
Apr 30
2021
|
William F Daniel Director |
SELL
Payment of exercise price or tax liability
|
Indirect |
2,993
-3.86%
|
$281,342
$94.62 P/Share
|
|
Apr 30
2021
|
William F Daniel Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
11,098
+12.53%
|
-
|
|
Apr 30
2021
|
Michael G Grey Director |
SELL
Payment of exercise price or tax liability
|
Indirect |
2,993
-4.08%
|
$281,342
$94.62 P/Share
|
|
Apr 30
2021
|
Michael G Grey Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
11,098
+13.14%
|
-
|
|
Apr 30
2021
|
Jeff Himawan Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
11,098
+17.05%
|
-
|
|
Apr 30
2021
|
Gino Santini Director |
SELL
Payment of exercise price or tax liability
|
Indirect |
4,357
-8.61%
|
$409,558
$94.62 P/Share
|
|
Apr 30
2021
|
Gino Santini Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
11,098
+17.99%
|
-
|
|
Apr 30
2021
|
James Samuel Shannon Director |
SELL
Payment of exercise price or tax liability
|
Indirect |
4,357
-9.75%
|
$409,558
$94.62 P/Share
|
|
Apr 30
2021
|
James Samuel Shannon Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
11,098
+19.89%
|
-
|
|
Apr 30
2021
|
Thomas Watkins Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
11,098
+13.53%
|
-
|
|
Apr 30
2021
|
Pascale Witz Director |
SELL
Payment of exercise price or tax liability
|
Indirect |
4,357
-9.53%
|
$409,558
$94.62 P/Share
|
|
Apr 30
2021
|
Pascale Witz Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
11,098
+19.54%
|
-
|
|
Apr 30
2021
|
Susan Mahony Director |
SELL
Payment of exercise price or tax liability
|
Indirect |
4,357
-23.67%
|
$409,558
$94.62 P/Share
|
|
Apr 30
2021
|
Susan Mahony Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
11,098
+37.61%
|
-
|
|
Apr 12
2021
|
Michael G Grey Director |
SELL
Open market or private sale
|
Direct |
15,000
-100.0%
|
$1,350,000
$90.28 P/Share
|
|
Apr 12
2021
|
Michael G Grey Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$30,000
$2.37 P/Share
|
|
Apr 12
2021
|
Barry Moze EVP, Chief Admin. Officer |
SELL
Open market or private sale
|
Direct |
65,613
-14.09%
|
$5,839,557
$89.53 P/Share
|
|
Apr 05
2021
|
Daniel A. Camardo EVP and President, U.S. |
BUY
Exercise of conversion of derivative security
|
Direct |
18,281
+10.17%
|
$347,339
$19.31 P/Share
|
|
Apr 01
2021
|
Geoffrey M. Curtis EVP, Corporate Affairs, CCO |
SELL
Open market or private sale
|
Direct |
70,739
-57.32%
|
$6,578,727
$93.51 P/Share
|
|
Apr 01
2021
|
Geoffrey M. Curtis EVP, Corporate Affairs, CCO |
BUY
Exercise of conversion of derivative security
|
Direct |
37,000
+14.03%
|
$1,036,000
$28.33 P/Share
|
|
Mar 31
2021
|
Brian K Beeler EVP, General Counsel |
SELL
Open market or private sale
|
Direct |
26,844
-21.91%
|
$2,415,960
$90.12 P/Share
|
|
Mar 30
2021
|
Daniel A. Camardo EVP and President, U.S. |
SELL
Open market or private sale
|
Direct |
12,900
-7.9%
|
$1,096,500
$85.33 P/Share
|
|
Mar 10
2021
|
Jeffrey W Sherman EVP and Chief Medical Officer |
BUY
Bona fide gift
|
Indirect |
66,730
+50.0%
|
-
|
|
Mar 10
2021
|
Jeffrey W Sherman EVP and Chief Medical Officer |
SELL
Bona fide gift
|
Direct |
66,730
-82.25%
|
-
|
|
Mar 01
2021
|
Timothy P Walbert Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
26,975
-1.42%
|
$2,454,725
$91.64 P/Share
|
|
Mar 01
2021
|
Gino Santini Director |
SELL
Open market or private sale
|
Direct |
12,000
-33.52%
|
$1,092,000
$91.47 P/Share
|
|
Mar 01
2021
|
James Samuel Shannon Director |
SELL
Open market or private sale
|
Direct |
7,232
-100.0%
|
$658,112
$91.3 P/Share
|
|
Mar 01
2021
|
James Samuel Shannon Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,232
+50.0%
|
$86,784
$12.19 P/Share
|